ENOV Insider Trading

Insider Ownership Percentage: 2.40%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Enovis Insider Trading History Chart

This chart shows the insider buying and selling history at Enovis by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$2M$0$2MTotal Insider BuyingTotal Insider Selling

Enovis Share Price & Price History

Current Price: $37.74
Price Change: Price Decrease of -1.142 (-2.94%)
As of 03/28/2025 04:59 PM ET

This chart shows the closing price history over time for ENOV up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMar$37.74Closing price on 03/29/25:

SEC Filings (Institutional Ownership Changes) for Enovis (NYSE:ENOV)

98.45% of Enovis stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ENOV by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$210Mbought$90MsoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$400M-$200M$0$200M$400MTotal InflowsTotal Outflows
Enovis logo
Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.
Read More on Enovis

Today's Range

Now: $37.74
Low: $37.39
High: $38.53

50 Day Range

MA: $42.06
Low: $35.55
High: $47.97

52 Week Range

Now: $37.74
Low: $35.14
High: $62.79

Volume

479,654 shs

Average Volume

706,157 shs

Market Capitalization

$2.15 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.05

Who are the company insiders with the largest holdings of Enovis?

Enovis' top insider investors include:
  1. Phillip Benjamin (Ben) Berry (CFO)
  2. Rajiv Vinnakota (Director)
  3. John Kleckner (Insider)
Learn More about top insider investors at Enovis.

Who are the major institutional investors of Enovis?

Enovis' top institutional shareholders include:
  1. T. Rowe Price Investment Management Inc. — 10.84%
  2. Vanguard Group Inc. — 9.65%
  3. Dimensional Fund Advisors LP — 5.10%
  4. Diamond Hill Capital Management Inc. — 4.91%
  5. DAVENPORT & Co LLC — 4.98%
  6. Royce & Associates LP — 4.35%
Learn More about top institutional investors of Enovis stock.

Which major investors are selling Enovis stock?

In the last quarter, ENOV stock was sold by these institutional investors:
  1. T. Rowe Price Investment Management Inc.
  2. Allspring Global Investments Holdings LLC
  3. Magnetar Financial LLC
  4. Price T Rowe Associates Inc. MD
  5. Diamond Hill Capital Management Inc.
  6. D. E. Shaw & Co. Inc.
  7. Dimensional Fund Advisors LP
  8. Thrivent Financial for Lutherans

Which major investors are buying Enovis stock?

Within the previous quarter, ENOV stock was acquired by institutional investors including:
  1. Hood River Capital Management LLC
  2. Paradigm Capital Management Inc. NY
  3. Raymond James Financial Inc.
  4. Raymond James Financial Inc.
  5. ExodusPoint Capital Management LP
  6. Adage Capital Partners GP L.L.C.
  7. Boston Partners
  8. Artemis Investment Management LLP